- The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline
[作者:Vinkers, CH; Mirza, NR; Olivier, B; Kahn, RS,期刊:Expert opinion on investigational drugs, 页码:1217-1233 , 文章类型: Review,,卷期:2010年19-10]
- Importance of the field: Cognitive impairments associated with schizophrenia include neuropsychological deficits in attention, working memory, learning and executive function. Because these cognitive deficits precede the...
- Aliskiren: beyond blood pressure reduction
[作者:Riccioni, G; Vitulano, N; Zanasi, A; Bellocci, F; d'Orazio, N,期刊:Expert opinion on investigational drugs, 页码:1265-1274 , 文章类型: Editorial Material,,卷期:2010年19-10]
- Importance of the field: Hypertension is one of the most important risk factors and causes of cardiovascular disease (CVD). From some years, renin-angiotensin-aldosterone system (RAAS) inhibitors such angiotensin convert...
- No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin
[作者:Derks, M; Abt, M; Parr, G; Meneses-Lorente, G; Young, AM; Phelan, M,期刊:Expert opinion on investigational drugs, 页码:1135-1145 , 文章类型: Article,,卷期:2010年19-10]
- Objectives: Dalcetrapib, which targets cholesteryl ester transfer protein, is in clinical development for prevention of cardiovascular events and is likely to be used concomitantly with statins. Two studies investigated ...
- Quetiapine: novel uses in the treatment of depressive and anxiety disorders
[作者:Ravindran, AV; Al-Subaie, A; Abraham, G,期刊:Expert opinion on investigational drugs, 页码:1187-1204 , 文章类型: Review,,卷期:2010年19-10]
- Importance of the field: Quetiapine, an atypical antipsychotic, has been approved for the treatment of schizophrenia, acute mania, bipolar depression and unipolar major depression. However, it is often used (off-label) t...
|